Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6267-6275

  Li, Gangyong ^a   Fridman, Rafael ^a   Choi Kim, Hyeong Reh ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; DOXORUBICIN; FOCAL ADHESION KINASE; HYDROGEN PEROXIDE; PROTEIN BCL 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL ADHESION; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELLS, CULTURED; ENZYME ACTIVATION; EPITHELIAL CELLS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 0033572494     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Lelievre, S., Weaver, V. M., and Bissell, M. J. Extracellular matrix signaling from the cellular membrane skeleton to the nuclear skeleton: a model of gene regulation. Recent Prog. Horm. Res., 51: 417-432, 1996.
2. Juliano, R. L., and Haskill, S. Signal transduction from the extracellular matrix. J. Cell Biol., 120: 577-585, 1993.
3. Guan, J. L., and Chen, H. C. Signal transduction in cell-matrix interactions. Int. Rev. Cytol., 168: 81-121, 1996.
4. Shi, Y. B., Li, Q., Damjanovski, S., Amano, T., and Ishizuya-Oka, A. Regulation of apoptosis during development: input from the extracellular matrix. Int. J. Mol. Med., 2: 273-282, 1998.
5. Richardson, A., and Parsons, J. T. Signal transduction through integrins: a central role for focal adhesion kinase? Bioessays, 17: 229-236, 1995.
6. Frisch, S. M., and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
7. Boudreau, N., Werb, Z., and Bissell, M. J. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA, 93: 3509-3513, 1996.
8. Lund, L. R., Romer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Dano, K., and Werb, Z. Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development (Camb.), 122: 181-193, 1996.
9. Boudreau, N., Sympson, C. J., Werb, Z., and Bissell, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Washington DC), 267: 891-893, 1995.
10. Alexander, C. M., Howard, E. W., Bissell, M. J., and Werb, Z. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene. J. Cell Biol., 135: 1669-1677, 1996.
11. Smith, M. R., Kung, H., Durum, S. K., Colburn, N. H., and Sun, Y. TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells. Cytokine, 9: 770-780, 1997.
12. Guedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A., and Stetler-Stevenson, M. In vivo suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Investig., 102: 2002-2010, 1998.
13. Guedez, L., Courtemanch, L., and Stetler-Stevenson, M. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood, 92: 1342-1349, 1998.
14. Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G., and Albini, A. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis [published erratum appears in Int. J. Cancer, 80: 485, 1999]. Int. J. Cancer, 75: 246-253, 1998.
15. Avalos, B. R., Kaufman, S. E., Tomonaga, M., Williams, R. E., Golde, D. W., and Gasson, J. C. K562 cells produce and respond to human erythroid-potentiating activity. Blood, 71: 1720-1725, 1988.
16. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., and Iwata, K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett., 298: 29-32, 1992.
17. Hayakawa, T., Yamashitam, K., Ohuchi, E., and Shinagawa, A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell Sci., 107: 2373-2379, 1994.
18. Baker, A. H., Zaltsman, A. B., George, S. J., and Newby, A. C. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Investig., 101: 1478-1487, 1998
19. Yamashita, K., Suzuki, M., Iwata, H., Koike, T., Hamaguchi, M., Shinagawa, A., Noguchi, T., and Hayakawa, T. Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS Lett., 396: 103-107, 1996.
20. Monaghan, P., Robertson, D., Amos, T. A., Dyer, M. J., Mason, D. Y., and Greaves, M. F. Ultrastructural localization of bcl-2 protein. J. Histochem. Cytochem., 40: 1819-1825, 1992.
21. Kroemer, G. The proto-oncogene Bcl-2 and its role in regulating apoptosis [published erratum appears in Nat. Med., 3: 934, 1997], Nat Med., 3: 614-620, 1997.
22. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis [see comments]. Science (Washington DC), 275: 1132-1136, 1997.
23. Kuo, T. H., Kim, H. R., Zhu, L., Yu, Y., Lin, H. M., and Tsang, W. Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene, 17: 1903-1910, 1998.
24. Frisch, S. M., Vuori, K., Kelaita, D., and Sicks, S. A role for Jun-N-terminal kinase in anoikis: suppression by bcl-2 and crmA. J. Cell Biol., 135: 1377-1382, 1996.
25. de Moissac, D., Mustapha, S., Greenberg, A. H., and Kirshenbaum, L. A. Bcl-2 activates the transcription factor NFκB through the degradation of the cytoplasmic inhibitor IκBα. J. Biol. Chem., 273: 23946-23951, 1998.
26. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, I., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075-6086, 1990.
27. Tait, L., Soule, H. D., and Russo, J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6087-6094, 1990.
28. Dawson, P. J., Wolman, S. R., Tait, L., Heppner, G. H., and Miller, F. R. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol., 148: 313-319, 1996.
29. Upadhyay, S., Li, G., Liu, H., Chen, Y. Q., Sarkar, F. H., and Kim, H. R. bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. Cancer Res., 55: 4520-4524, 1995.
30. Fridman, R., Fuerst, T. R., Bird, R. E., Hoyhtya, M., Oelkuct, M,. Kraus, S., Komarek, D., Liotta, L. A., Berman, M. L., and Stetler-Stevenson, W. G. Domain structure of human 72-κDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J. Biol. Chem., 267: 15398-15405, 1992.
31. Fridman, R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Komarek, D., Liang, C. M., Berman, M. L., Liotta, L. A., Stetler-Stevenson, W. G., and Fuerst, T. R. Expression of human recombinant 72 κDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochem. J., 289: 411-416, 1993.
32. Olson, M. W., Gervasi, D. C., Mohashery, S., and Fridman, R. Kinetic analysis of the binding of human matrix meralloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem., 272: 29975-29983, 1997.
33. Ruoslahti, E., and Reed, J. C. Anchorage dependence, integrins, and apoprosis. Cell. 77: 477-478, 1994.
34. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
35. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, W: 11-25, 1992.
36. Guan, J. L., and Shalloway, D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature (Lond.), 358: 690-692, 1992.
37. Lipfert, L., Haimovich, B., Schaller, M. D., Cobb, B. S., Parsons, J. T., and Brugge, J. S. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J. Cell Biol., 119: 905-912, 1992.
38. Day, M. L., Foster, R. G., Day, K. C., Zhao, X., Humphrey, P., Swanson, P., Postigo, A. A., Zhang, S. H., and Dean, D. C. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J. Biol. Chem., 272: 8125-8128, 1997.
39. Frisch, S. M., Vuori, K., Ruoslahti, E., and Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol., 134: 793-799, 1996.
40. Sonoda, Y., Kasahara, T., Yokota-Aizu, E., Ueno, M., and Watanabe, S. A suppressive role of p125FAK protein tyrosine kinase in hydrogen peroxide-induced apoptosis of T98G cells. Biochem. Biophys. Res. Commun., 241: 769-774, 1997.
41. Adams, J. M.,. and Cory.,S. The Bcl-2 protein family: arbiters of cell survival. Science (Washington DC), 281: 1322-1326, 1998.
42. Merry, D. E., and Korsmeyer, S. J. Bcl-2 gene family in the nervous system. Annu. Rev. Neurosci., 20: 245-267, 1997.
43. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J., 326: 1-16, 1997.
44. Nicholson, D.W., and Thornberry, N. A. Caspases: killer proteases. Trends Biochem. Sci., 22: 299-306, 1997.
45. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. Apaf-I, a human protein homologous to C, elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 [see comments]. Cell, 90: 405-413, 1997.
46. Sonoda, Y., Watanabe, S., Matsumoto, Y., Aizu-Yokota, E., and Kasahara, T. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J. Biol. Chem., 274: 10566-10570, 1999.
47. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (Washington DC), 275: 661-665, 1997.
48. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91: 231-241, 1997.
49. Bertaux, B., Hornebeck, W., Eisen, A. Z., and Dubertrel, L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Invrstig. Dermatol., 97: 679-685, 1991.
50. Zhu, X., Ohtsubo, M., Bohmer, R. M., Roberts, J. M., and Assoian, R. K. Adhesion dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol., 133: 391-403, 1996.
51. Tryggvason, K., Hoyhtya, M., and Salo, T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta, 907: 191-217, 1987.
52. Tryggvason, K., Hoyhtya, M., and Pyke, C. Type IV collagenases in invasive tumors. Breast Cancer Res. Treat., 24: 209-218, 1993.
53. Stetler-Stevenson, W. G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9: 289-303, 1990.
54. Ura, H., Bonfil, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C., and Klein-Szanto, A. J. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res., 49: 4615-4621, 1989.
55. Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., and Fidler, I. J. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res., 48: 6863-6871, 1988.
56. DeClerck, Y. A., Perez, N., Shimada, H., Boone, T. C., Langley, K. E., and Taylor, S. M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52: 701-708, 1992.
57. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
58. Yoshiji, H., Gomes, D. E., and Thorgeirsson, U. P. Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer. Int J. Cancer, 69: 131-134, 1996.
59. McCarthy, K., Maguire, T., McGreal, G., McDermott, E., O'Higgins, N., and Duffy, M. J. High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer Int. J. Cancer, 84: 44-48, 1999.
60. Ree, A. H., Florenes, V. A., Berg, J. P., Maelandsmo, G. M., Nesland, J. M., and Fodstad, O. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res., 3: 1623-1628, 1997.
61. Zeng, Z. S., Cohen, A. M., Zhang, Z. F., Stetler-Stevenson, W., and Guillem, J. G. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin. Cancer Res., 1: 899-906, 1995.
62. Mimori, K., Mori, M., Shiraishi, T., Fujie, T., Baba, K., Haraguchi, M., Abe, R., Ueo, H., and Akiyoshi, T. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br. J. Cancer, 76: 531-536, 1997.
63. Kossakowska, A. E., Urbanski, S. J., and Edwards, D. R. Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood, 77: 2475-2481, 1991.
64. Fong, K. M., Kida, Y., Zimmerman, P. V., and Smith, P. J. TIMP1 and adverse prognosis in non-small cell lung cancer. Clin. Cancer Res., 2: 1369-1372, 1996.